Updated results of the FLAC European database of metastatic castration resistant prostate cancer (mCRPC) patients (pts) treated with life extending therapies in post-docetaxel (D) setting
| dc.contributor.author | Munarriz, J. | |
| dc.contributor.author | Flechon, A. | |
| dc.contributor.author | Guillot, A. | |
| dc.contributor.author | Le Moulec, S. | |
| dc.contributor.author | Castellano, D. | |
| dc.contributor.author | Esteban, E. | |
| dc.contributor.author | Campos Balea, B. | |
| dc.contributor.author | Ozguroglu, M. | |
| dc.contributor.author | Bellmunt, J. | |
| dc.contributor.author | Stefanou, D. | |
| dc.contributor.author | Ardavanis, A. | |
| dc.contributor.author | Oudard, S. | |
| dc.contributor.author | Angelergues, A. | |
| dc.contributor.author | Efstathiou, E. | |
| dc.contributor.author | Gonzalez, I. | |
| dc.contributor.author | Gyftaki, R. | |
| dc.contributor.author | Delanoy, N. | |
| dc.date.accessioned | 2021-03-05T16:03:07Z | |
| dc.date.available | 2021-03-05T16:03:07Z | |
| dc.identifier.citation | Oudard S., Angelergues A., Efstathiou E., Gonzalez I., Gyftaki R., Delanoy N., Ozguroglu M., Flechon A., Guillot A., Le Moulec S., et al., "Updated results of the FLAC European database of metastatic castration resistant prostate cancer (mCRPC) patients (pts) treated with life extending therapies in post-docetaxel (D) setting", European Cancer Congress, Vienna, Avusturya, 01 Ocak 2015, cilt.51 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.other | av_beccd31d-e724-4b7a-9498-8709be1bf5e4 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/126706 | |
| dc.identifier.uri | https://doi.org/10.1016/s0959-8049(16)31360-0 | |
| dc.language.iso | eng | |
| dc.subject | Onkoloji | |
| dc.subject | ONKOLOJİ | |
| dc.subject | Klinik Tıp | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Tıp | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Dahili Tıp Bilimleri | |
| dc.subject | İç Hastalıkları | |
| dc.title | Updated results of the FLAC European database of metastatic castration resistant prostate cancer (mCRPC) patients (pts) treated with life extending therapies in post-docetaxel (D) setting | |
| dc.type | Bildiri | |
| dc.contributor.department | Assistance Publique Hopitaux Paris (APHP) , , | |
| dc.identifier.volume | 51 | |
| dc.contributor.firstauthorID | 147782 |
Bu öğenin dosyaları:
| Dosyalar | Boyut | Biçim | Göster |
|---|---|---|---|
|
Bu öğe ile ilişkili dosya yok. |
|||
Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.
-
Bildiri [64839]